Novo files for hemophilia drug OK; Fate Therapeutics names new CEO; Shenzhen Hepalink invests in ProMetic;

 @FierceBiotech: New special report on 10 promising therapeutic vaccines in 2012. Feature | Follow @FierceBiotech

 @JohnCFierce: Genzyme, likely to get some tough safety questions on Kynamro at this week's FDA panel. More | Follow @JohnCFierce

 @RyanMFierce: Piramal is poised to be a big consolidator in pharma services/manufacturing, but apparently only at the right price. More | Follow @RyanMFierce

> Novo Nordisk ($NVO) has filed for regulatory approval of its hemophilia drug Turoctocog Alfa in the U.S. and Europe. Report

> Fate Therapeutics named Christian Weyer as its new president and chief executive officer. Release

> China's Shenzhen Hepalink Pharmaceutical is making a $10 million investment in Canada's ProMetic Life Sciences while striking two R&D pacts worth up to $21 million. Story

Pharma News

@FiercePharma: Other compounded drugs may be tied into meningitis outbreak, FDA says. Another NECC steroid + NECC heart drug. More | Follow @FiercePharma

> J&J credits Remicade, Zytiga for 7% hike in Q3 drug sales. Story

> Roche sales hike sums up pharma hopes for cancer, emerging markets. Article

> India kicks branded generics to the curb. Report

Medical Device News

 @FierceMedDev: JNJ pulled in $7.1 billion from medical devices and diagnostics in Q3, a 12.5% jump. More | Follow @FierceMedDev

 @MarkHFierce: Patients in India thrived with used ICD implants. Can this be done on a broader scale? More | Follow @MarkHFierce

 @DamianFierce: Medtronic is buying a $66.2M stake in China's LifeTech Scientific, makers of cardiovascular devices. More | Follow @DamianFierce

> Amid Dx sales growth, Roche Diagnostics considers another buy. News

> Lanx draws $8.7M for spinal fusion device development. Item

Biotech Research News

> NIH funds Advanced Cancer Therapeutics' preclinical brain cancer drug work. Report

> Scientists flee $3B Texas cancer research fund. Item

> Alnylam, Tel Aviv U develop RNAi drugs to fight rare blood cancer. Article

> Alzheimer's drug builds new brain cell connections in rats. News

> Scientists build neural-like stem cells from mouse muscle tissue. Story

Pharma Manufacturing News

> GSK cancels plans to close Stiefel plant in Ireland. Story

> Cinven continues generics deal spree with Amdipharm buy. Article

> Teva Pharma opens $110M plant in Hungary. News

> Analysis: Compounding groups fought FDA oversight before NECC disaster. Report

And Finally... Postdoctoral Research Fellow Devin Koestler and colleagues are investigating the potential use of white blood cell variation as a diagnostic and research tool for cancer. Release


Suggested Articles

The delay will enable Anixa to perform additional genetic engineering intended to boost the efficacy of the treatment in ovarian cancer.

The new parliamentary arithmetic gives Boris Johnson the numbers to pass the withdrawal agreement and take the U.K. out of the EU.

The discovery that 500 cancers can be slotted into 10 subtypes, each of which is driven by a common set of proteins, could inspire new therapies.